<SEC-DOCUMENT>0001789769-23-000067.txt : 20230511
<SEC-HEADER>0001789769-23-000067.hdr.sgml : 20230511
<ACCEPTANCE-DATETIME>20230511070549
ACCESSION NUMBER:		0001789769-23-000067
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230511
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230511
DATE AS OF CHANGE:		20230511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Instil Bio, Inc.
		CENTRAL INDEX KEY:			0001789769
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				832072195
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40215
		FILM NUMBER:		23908768

	BUSINESS ADDRESS:	
		STREET 1:		3963 MAPLE AVENUE
		STREET 2:		SUITE 350
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75219
		BUSINESS PHONE:		(972) 499-3350

	MAIL ADDRESS:	
		STREET 1:		3963 MAPLE AVENUE
		STREET 2:		SUITE 350
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>til-20230511.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:935938fb-4a54-49d2-8150-1597aaa7e964,g:9071c47c-869f-40c0-bf9b-ab0c463e9a31,d:ba70601418a64178a1f964c2efe7357c--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>til-20230511</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y180L2ZyYWc6MTUxNjNlYTNmZjQzNDU1MGIwMDdjZTI0YWVkMjk3MmQvdGFibGU6ZjBjMjI3M2M4YTI0NDdjZmI0NGFjZTg1MTNlNmQzZTkvdGFibGVyYW5nZTpmMGMyMjczYzhhMjQ0N2NmYjQ0YWNlODUxM2U2ZDNlOV8wLTEtMS0xLTEwNzUzNw_a30c3873-38e0-4786-a9ca-4e6857c30d47">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y180L2ZyYWc6MTUxNjNlYTNmZjQzNDU1MGIwMDdjZTI0YWVkMjk3MmQvdGFibGU6ZjBjMjI3M2M4YTI0NDdjZmI0NGFjZTg1MTNlNmQzZTkvdGFibGVyYW5nZTpmMGMyMjczYzhhMjQ0N2NmYjQ0YWNlODUxM2U2ZDNlOV8xLTEtMS0xLTEwNzUzNw_f88ea521-21d1-4155-a32e-1f03a32605d1">0001789769</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="til-20230511.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if06a677972274e868f9b232838c40b92_D20230511-20230511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001789769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-11</xbrli:startDate><xbrli:endDate>2023-05-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iba70601418a64178a1f964c2efe7357c_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549 </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQy_1024db81-9c59-4c82-9f65-b11105b3f126">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV81NDk3NTU4MTYyNDA_15d52cd3-2c2a-4302-ae2c-b848f7cc9472">May&#160;11, 2023</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ0_948e46cd-25de-49dc-909e-29664ffca998">Instil Bio, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its Charter) </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzA0MTE3ZjY0ZjM2NDE1Mjg1ZDBlNWQ1MzBmYWVmMDAvdGFibGVyYW5nZTo3MDQxMTdmNjRmMzY0MTUyODVkMGU1ZDUzMGZhZWYwMF8wLTAtMS0xLTEwNzUzNw_38177d4b-9d19-4b39-b535-04575649dc01">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzA0MTE3ZjY0ZjM2NDE1Mjg1ZDBlNWQ1MzBmYWVmMDAvdGFibGVyYW5nZTo3MDQxMTdmNjRmMzY0MTUyODVkMGU1ZDUzMGZhZWYwMF8wLTEtMS0xLTEwNzUzNw_c0482bb7-ecdc-4fc5-99ea-f72d6c847081">001-40215</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzA0MTE3ZjY0ZjM2NDE1Mjg1ZDBlNWQ1MzBmYWVmMDAvdGFibGVyYW5nZTo3MDQxMTdmNjRmMzY0MTUyODVkMGU1ZDUzMGZhZWYwMF8wLTItMS0xLTEwNzUzNw_acb04e75-64b0-40f4-881a-ea47d4884479">83-2072195</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(State or Other Jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOmZiYzQxZTlmNDgxOTRkNDY5ZDYwZmQ4NGJmMDI3MjRlXzU_1251bce5-2051-4890-8829-2cb83497dbf7">3963 Maple Avenue, Suite 350</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOmZiYzQxZTlmNDgxOTRkNDY5ZDYwZmQ4NGJmMDI3MjRlXzg_7da8730f-c745-479b-8c2d-513e491272fe">Dallas</ix:nonNumeric>, <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOmZiYzQxZTlmNDgxOTRkNDY5ZDYwZmQ4NGJmMDI3MjRlXzEy_a1b57268-7e89-4f96-8850-d04d352e0dc0">Texas</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTItMS0xLTEwNzUzNw_96419166-17f0-4e7c-bdaf-f1e1701efba6">75219</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ1_b6feede1-1cac-4e24-b3a9-eb86f9c4bd93">972</ix:nonNumeric>) <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ2_fc785d5d-bb09-4e1a-b2d7-b9cfc3079665">499-3350</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code) </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report) </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6MjhjZmViZWFhMTc3NGI2MGE5YTRmODJiNGM1YTgzYzQvdGFibGVyYW5nZToyOGNmZWJlYWExNzc0YjYwYTlhNGY4MmI0YzVhODNjNF8wLTAtMS0xLTEwNzUzNw_4e533fec-f412-4966-a81f-37f1259988ec">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.577%"><tr><td style="width:1.0%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6YzM0ZDRmNjA4ZDg3NDZlN2FhYTk1YzkyYWEzMWNlODQvdGFibGVyYW5nZTpjMzRkNGY2MDhkODc0NmU3YWFhOTVjOTJhYTMxY2U4NF8wLTAtMS0xLTEwNzUzNw_01b92cd9-62ec-4886-956e-39698d981d03">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6ZjBhNjNmMWY0YzFhNDdkZjg0YTg5NjRiNmI0MDRkYWEvdGFibGVyYW5nZTpmMGE2M2YxZjRjMWE0N2RmODRhODk2NGI2YjQwNGRhYV8wLTAtMS0xLTEwNzUzNw_bf78f2b5-97fd-4a65-b499-998bc0bb3e8d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzRiNTkzYWMyMmMxNDMxMWEzMGI2OTNhZjM4ZGMwNjkvdGFibGVyYW5nZTo3NGI1OTNhYzIyYzE0MzExYTMwYjY5M2FmMzhkYzA2OV8wLTAtMS0xLTEwNzUzNw_0b41d9f7-5fae-45ba-8bff-0d3195fde70a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:36.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NTEyODM5YWZkYjM2NDQ1ZGEwYjc2NDU2OThkMGUxMmEvdGFibGVyYW5nZTo1MTI4MzlhZmRiMzY0NDVkYTBiNzY0NTY5OGQwZTEyYV8xLTAtMS0xLTEwNzUzNw_97011d8f-633c-41ce-9f02-6486e22a4653">Common Stock, $0.000001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NTEyODM5YWZkYjM2NDQ1ZGEwYjc2NDU2OThkMGUxMmEvdGFibGVyYW5nZTo1MTI4MzlhZmRiMzY0NDVkYTBiNzY0NTY5OGQwZTEyYV8xLTItMS0xLTEwNzUzNw_5ae8c2d1-e8d8-446e-b099-d625c5560ca1">TIL</ix:nonNumeric></span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NTEyODM5YWZkYjM2NDQ1ZGEwYjc2NDU2OThkMGUxMmEvdGFibGVyYW5nZTo1MTI4MzlhZmRiMzY0NDVkYTBiNzY0NTY5OGQwZTEyYV8xLTQtMS0xLTEwNzUzNw_c02f9954-1380-4cd8-bd7c-285e5ac8cd91">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ4_e8b68481-a70a-44f9-999a-1ce8c96e4f62">&#9746;</ix:nonNumeric> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ5_e8c814eb-ba94-4271-bd63-72dbc38f3368">&#9744;</ix:nonNumeric> &#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV81NDk3NTU4MTYyNDQ_15d52cd3-2c2a-4302-ae2c-b848f7cc9472">May&#160;11, 2023</ix:nonNumeric>, Instil Bio, Inc. (the &#8220;Company&#8221;) provided a corporate update and announced its financial results for the quarter ended March&#160;31, 2023 in the press release attached hereto as Exhibit 99.1, which is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Exhibits</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.309%"><tr><td style="width:1.0%"></td><td style="width:7.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm">Press release, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm">May</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="q1-23er.htm">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The cover page of this report has been formatted in Inline XBRL.</span></td></tr></table></div><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.767%"><tr><td style="width:1.0%"></td><td style="width:31.928%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.850%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Instil Bio, Inc.</span></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dated: <ix:nonNumeric contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6OWIzNjQ3MDI4ODI3NDAzZTkwMjE0ZGMxMGMwODI3NDkvdGFibGVyYW5nZTo5YjM2NDcwMjg4Mjc0MDNlOTAyMTRkYzEwYzA4Mjc0OV8zLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOjk4YThiMGI5MDdhMDQ4ZmVhOWM3YWEzN2FjOGE1MTFiXzU0OTc1NTgxMzkwMg_15d52cd3-2c2a-4302-ae2c-b848f7cc9472">May&#160;11, 2023</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Sandeep Laumas, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sandeep Laumas, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Financial Officer and Chief Business Officer<br/>(Principal Financial Officer and Principal Accounting Officer)</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q1-23er.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2830dc3d990e4a7eb971ebe0acecc9e0_1"></div><div style="min-height:93.1pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:137px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Instil Bio Reports First Quarter 2023 Financial Results and </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Provides Corporate Update</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">ITIL-306 phase 1 study anticipated to receive CTA clearance from UK MHRA in 2H</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8217;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">2023</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Anticipate initial clinical data from ITIL-306 phase 1 program in 2024</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Cash runway beyond 2026</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">DALLAS, TX, May&#160;11, 2023 (GLOBE NEWSWIRE) -- </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Instil Bio, Inc. (&#8220;Instil&#8221;) (NASDAQ&#58; TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today reported its first quarter 2023 financial results and provided a corporate update.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">First Quarter 2023 Highlights and Anticipated Milestones&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">ITIL-306 phase 1 study in UK anticipated to initiate in 2H&#8217;2023</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#58; Instil has recently received positive initial feedback from the Medicines and Healthcare products Regulatory Agency, or MHRA, on the proposed study design for the phase 1 dose escalation study of ITIL-306 in the United Kingdom, and anticipates initiating such study in the second half of 2023 following anticipated Clinical Trial Application, or CTA, clearance from the MHRA. Instil expects to report initial clinical data from the ITIL-306 program in 2024.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;padding-left:12.53pt">Instil confirms cash runway beyond 2026 with consolidation of R&#38;D operations to the UK</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#58; In January 2023, the Company announced the consolidation of the Phase 1 clinical trial and related manufacturing of CoStAR-TIL&#8482; to its active operations in Manchester, UK leading to an extension of the expected cash runway to beyond 2026. Instil&#8217;s Manchester, UK operations have extensive experience in the manufacture and development of TIL and other cell therapies since 2011. Instil continues to pursue a potential lease or sale of its manufacturing facility in Tarzana, California. Under the current operating plan, starting in the second half of 2023, Instil expects quarterly cash burn of less than $10 million through the end of 2024.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">First Quarter 2023 Financial and Operating Results&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of March&#160;31, 2023, Instil had cash, cash equivalents, restricted cash and marketable securities of $223.9&#160;million, which consists of $27.4&#160;million in cash and cash equivalents, $0.7&#160;million in restricted cash and $195.8&#160;million in marketable securities, compared to $260.9&#160;million in total cash and cash equivalents and marketable securities, consisting of $43.7 million in cash and cash equivalents and $217.2&#160;million in marketable securities as of December&#160;31, 2022. Instil expects that its cash, cash equivalents and marketable securities as of March&#160;31, 2023 will enable it to fund its operating plan beyond 2026.</font></div><div><font><br></font></div><div style="padding-left:0.36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development expenses were $20.7 million for the three months ended March&#160;31, 2023, compared to $39.2 million for the three months ended March&#160;31, 2022.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General and administrative expenses were $13.2 million for the three months ended March&#160;31, 2023, compared to $15.1 million for the three months ended March&#160;31, 2022.</font></div><div style="padding-left:0.36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.1pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:137px"></div></div><div style="padding-left:0.36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restructuring and impairment charges were $24.6 million for the three months ended March&#160;31, 2023.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INSTIL BIO, INC.</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SELECTED FINANCIAL DATA </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; in thousands, except share and per share amounts) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Selected Balance Sheet Data</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:65.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">March 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">December 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash, cash equivalents, restricted cash  and marketable securities</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">223,870&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">260,920&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total assets</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">427,172&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">482,128&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total liabilities</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">116,018&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">118,523&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stockholders&#8217; equity</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">311,154&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">363,605&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.1pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:137px"></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Statements of Operations</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:65.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20,670&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">39,174&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13,222&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15,112&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restructuring and impairment charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24,554&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58,446&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54,286&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(58,446)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(54,286)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2,071&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">97&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(636)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other expense, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(57)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(416)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Loss before income tax expense</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(57,068)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(54,605)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Income tax benefit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">488&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(57,068)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(54,117)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(0.44)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(0.42)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net loss per share, basic and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">130,079,097&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">129,119,462&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note Regarding Use of Non-GAAP Financial Measures</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In this press release, Instil Bio has presented certain financial information that has not been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). These non-GAAP financial measures include non-GAAP net loss and non-GAAP net loss per share, which are defined as net loss and net loss per share, respectively, excluding non-cash stock-based compensation expense. Instil Bio believes that these non-GAAP financial measures, when considered together with the GAAP figures, can enhance an overall understanding of Instil Bio&#8217;s financial performance. The non-GAAP financial measures are included with the intent of providing investors with a more complete understanding of Instil Bio&#8217;s operating results. In addition, these non-GAAP financial measures are among the indicators Instil Bio&#8217;s management uses for planning purposes and to measure Instil Bio&#8217;s performance. These non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. The non-GAAP financial measures used by Instil Bio may be calculated differently from, and therefore may not be comparable to, non-GAAP financial measures used by other companies. Please refer to the below reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.1pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:137px"></div></div><div><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">INSTIL BIO, INC.</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Net Loss </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Unaudited&#59; in thousands, except share and per share amounts) </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:65.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(57,068)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(54,117)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-cash stock-based compensation expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4,530&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7,493&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(52,538)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(46,624)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(0.44)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(0.42)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-cash stock-based compensation expense per share</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.06&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP net loss per share, basic and diluted*</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(0.41)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(0.36)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Weighted-average shares outstanding, basic and diluted</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">130,079,097&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">129,119,462&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">*  Non-GAAP net loss per share, basic and diluted may not total due to rounding.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Instil Bio</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Instil Bio, Inc. (Nasdaq&#58; TIL) is a clinical-stage biopharmaceutical company focused on developing TIL therapies for the treatment of patients with cancer. Instil has assembled an accomplished management team with a successful track record in the research, development and manufacture of cell therapies. Using its proprietary and optimized manufacturing processes at its in-house manufacturing facilities, Instil is developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR&#8482;, platform, including ITIL-306, a next-generation, genetically-engineered TIL therapy using the CoStAR platform, for multiple solid tumors. For more information visit </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">www.instilbio.com</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;projects,&#8221; and &#8220;will&#8221; or similar expressions are intended to identify forward-looking statements. Forward-looking statements include statements concerning or implying the therapeutic potential of our product candidates, our research, development and regulatory plans for our product candidates, including our expectations of CTA clearance from the MHRA, the timing of our ongoing and potential future clinical trials and studies and the availability and presentation of data therefrom, including our expectations concerning the initiation of, and timing of updates on our ITIL-306 clinical trial in the United Kingdom, the potential for us to make submissions concerning, and for our product candidates to receive, regulatory approval from the FDA, MHRA or equivalent foreign regulatory agencies and whether, if approved, these product candidates will be successfully distributed and marketed, the anticipated sale or lease of our Tarzana, California manufacturing facility, our cash runway </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.1pt;width:100%"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:137px"></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and quarterly cash burn, and other statements that are not historical fact. Forward-looking statements are based on management's current expectations and are subject to various risks and uncertainties that could cause actual results to differ materially and adversely from those expressed or implied by such forward-looking statements, including risks and uncertainties associated with the costly and time-consuming cell therapy product development process and the uncertainty of clinical success, including risks related to failure or delays in successfully initiating, enrolling, reporting data from or completing clinical studies, as well as the risks that results obtained in clinical trials to date may not be indicative of results obtained in ongoing or future trials and that Instil</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8217;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">s product candidates may otherwise not be effective treatments in their planned indications&#59; macroeconomic conditions, including as a result of the ongoing COVID-19 pandemic, the ongoing conflict between Russia and Ukraine, bank failures and other factors, which could materially and adversely affect Instil</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8217;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">s business and operations, including Instil's ability to timely initiate, enroll and complete its ongoing and future clinical trials&#59; the time-consuming and uncertain regulatory approval process&#59; risks inherent in manufacturing and testing of cell therapy products&#59; the sufficiency of Instil</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8217;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">s cash resources, and other risks and uncertainties affecting Instil and its development programs, including those discussed in the section titled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> year ended</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> December&#160;31, 2022 available on the SEC&#8217;s website at www.sec.gov, and in our Quarterly Report on Form 10-Q for the quarter ended </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">March&#160;31, 2023</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> to be filed with the SEC. Additional information will be made available in other filings that we make from time to time with the SEC. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as the date hereof, and we disclaim any obligation to update these statements except as may be required by law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contacts&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Investor Relations</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">1-972-499-3350</font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">investorrelations&#64;instilbio.com</font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.instilbio.com</font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">###</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>til-20230511.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:935938fb-4a54-49d2-8150-1597aaa7e964,g:9071c47c-869f-40c0-bf9b-ab0c463e9a31-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:til="http://instilbio.com/20230511" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://instilbio.com/20230511">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="til-20230511_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="til-20230511_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://instilbio.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>til-20230511_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:935938fb-4a54-49d2-8150-1597aaa7e964,g:9071c47c-869f-40c0-bf9b-ab0c463e9a31-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_90cec79e-f9cf-44ae-979a-a13f8bdcfc34_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_dc044d26-0929-4f9c-a8ec-f7ac099abf21_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6aee6fbe-89d2-4e55-a9ee-d0a02099e90c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e1f78ac3-bbe1-4476-a51d-ab65f7d7a60a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c249d0c2-4c7e-43a2-9123-7b31b620cc0e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_8e3cbe3e-96f7-4ce9-8d91-244e16c60ecf_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_e60c0da5-1438-457a-ab7b-c2b6c4ee06d1_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c3dfd2de-3a82-42ff-a0e3-e5cc20a53e23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fcbc5441-3652-4008-827e-d2acfa122659_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_42c9ef78-28ac-4072-9ae9-a450ae1a6c05_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_63ef286f-858a-4423-a3a5-c0da04b1cbc6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_731e4993-b279-4783-bbce-0cd9fca95180_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_70b1e81b-c70b-47f1-843d-a3480af31680_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f5806d07-1095-41f6-bfaf-b908f3e37659_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6e5b2281-d07f-4eec-a2eb-db7a7dfe0fa0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_991a3c77-6be0-4f97-ad7f-f0edcbf2d1cb_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_add98b87-2533-43c0-9ffa-017025ee480e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_427ce28c-f2fe-4db0-a539-087b4ddb7ccf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0a674db2-6db1-457d-8bcc-9fe885f421dc_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_00f69aed-ff90-4545-a596-20892cfedefc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9d04d3aa-45bb-4b8f-bfcf-2769b9b7250a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d2ae6a58-b17c-4fc6-a132-004b063acb27_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f84f29bd-970f-4158-bf1f-d9629cb06344_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>til-20230511_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:935938fb-4a54-49d2-8150-1597aaa7e964,g:9071c47c-869f-40c0-bf9b-ab0c463e9a31-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://instilbio.com/role/Cover" xlink:type="simple" xlink:href="til-20230511.xsd#Cover"/>
  <link:presentationLink xlink:role="http://instilbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a3a3688a-0149-467d-a33d-acb1d486fb84" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_DocumentType_a3a3688a-0149-467d-a33d-acb1d486fb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3e0860f9-e2dd-4a26-9d51-4d66bf74031f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_DocumentPeriodEndDate_3e0860f9-e2dd-4a26-9d51-4d66bf74031f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9fe7d133-0a2d-4dce-93b6-5000c88aef85" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityRegistrantName_9fe7d133-0a2d-4dce-93b6-5000c88aef85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16d0e502-8ddd-4197-8c3c-240e102bbf38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityIncorporationStateCountryCode_16d0e502-8ddd-4197-8c3c-240e102bbf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_74bf019d-cfe6-408a-9773-e41fe0d87cc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityFileNumber_74bf019d-cfe6-408a-9773-e41fe0d87cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_34fb5a79-8db1-49a7-b715-bc46230f73cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityTaxIdentificationNumber_34fb5a79-8db1-49a7-b715-bc46230f73cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_94d0d312-ae6f-43e3-999e-bc114b5c7ad0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityAddressAddressLine1_94d0d312-ae6f-43e3-999e-bc114b5c7ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7466eead-0c18-47c9-88d9-ad1ffac8b50f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityAddressCityOrTown_7466eead-0c18-47c9-88d9-ad1ffac8b50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3f717870-df8d-4cc4-addf-602e9b656d54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityAddressStateOrProvince_3f717870-df8d-4cc4-addf-602e9b656d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3d38b3ba-7a9f-449d-855f-101dd8d7af59" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityAddressPostalZipCode_3d38b3ba-7a9f-449d-855f-101dd8d7af59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a436c206-b326-4c33-bebe-8d85a51bf355" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_CityAreaCode_a436c206-b326-4c33-bebe-8d85a51bf355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8f0c67e7-3c60-46c9-871d-2cd4fd73a77f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_LocalPhoneNumber_8f0c67e7-3c60-46c9-871d-2cd4fd73a77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7d178eb9-2a05-4520-a714-a997a191b15d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_WrittenCommunications_7d178eb9-2a05-4520-a714-a997a191b15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e7302d87-771b-4bd2-98f4-66a60ba5ede2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_SolicitingMaterial_e7302d87-771b-4bd2-98f4-66a60ba5ede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_365f3d43-23e7-4367-8c96-91a414dc6f92" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_PreCommencementTenderOffer_365f3d43-23e7-4367-8c96-91a414dc6f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_2f629395-e7a5-4466-8a70-7e0e80d18f44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_2f629395-e7a5-4466-8a70-7e0e80d18f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0b203976-3505-4088-b41a-69f5991334cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_Security12bTitle_0b203976-3505-4088-b41a-69f5991334cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_976654f8-cca4-4028-9b3f-492f48ef7339" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_TradingSymbol_976654f8-cca4-4028-9b3f-492f48ef7339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_570c0912-898e-4085-8cff-249c8330e66c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_SecurityExchangeName_570c0912-898e-4085-8cff-249c8330e66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_25fdf6f2-7340-4e73-9dee-8cf358c44115" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityEmergingGrowthCompany_25fdf6f2-7340-4e73-9dee-8cf358c44115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_6d4e97c0-4875-4b56-a6bc-e34e0ee66fd7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityExTransitionPeriod_6d4e97c0-4875-4b56-a6bc-e34e0ee66fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6bda6091-aa9b-4d0d-9bbb-56c2f802d55b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_AmendmentFlag_6bda6091-aa9b-4d0d-9bbb-56c2f802d55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_259ee3db-a305-4e69-844f-8fa5dc5bf6e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_71a05d46-3355-440c-8a89-4124125a7bfc" xlink:to="loc_dei_EntityCentralIndexKey_259ee3db-a305-4e69-844f-8fa5dc5bf6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>imagea.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imagea.jpg
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M7G@EE0 )K]3!3V$$2/BI%UY))4#"*W7P4Q@!$G[JA5=2_1=ZUW*_BSPBF@
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140245196680384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 11, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 11,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Instil Bio, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2072195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3963 Maple Avenue, Suite 350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">499-3350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.000001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TIL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001789769<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>til-20230511_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="til-20230511.xsd" xlink:type="simple"/>
    <context id="if06a677972274e868f9b232838c40b92_D20230511-20230511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789769</identifier>
        </entity>
        <period>
            <startDate>2023-05-11</startDate>
            <endDate>2023-05-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y180L2ZyYWc6MTUxNjNlYTNmZjQzNDU1MGIwMDdjZTI0YWVkMjk3MmQvdGFibGU6ZjBjMjI3M2M4YTI0NDdjZmI0NGFjZTg1MTNlNmQzZTkvdGFibGVyYW5nZTpmMGMyMjczYzhhMjQ0N2NmYjQ0YWNlODUxM2U2ZDNlOV8wLTEtMS0xLTEwNzUzNw_a30c3873-38e0-4786-a9ca-4e6857c30d47">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y180L2ZyYWc6MTUxNjNlYTNmZjQzNDU1MGIwMDdjZTI0YWVkMjk3MmQvdGFibGU6ZjBjMjI3M2M4YTI0NDdjZmI0NGFjZTg1MTNlNmQzZTkvdGFibGVyYW5nZTpmMGMyMjczYzhhMjQ0N2NmYjQ0YWNlODUxM2U2ZDNlOV8xLTEtMS0xLTEwNzUzNw_f88ea521-21d1-4155-a32e-1f03a32605d1">0001789769</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQy_1024db81-9c59-4c82-9f65-b11105b3f126">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV81NDk3NTU4MTYyNDA_15d52cd3-2c2a-4302-ae2c-b848f7cc9472">2023-05-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ0_948e46cd-25de-49dc-909e-29664ffca998">Instil Bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzA0MTE3ZjY0ZjM2NDE1Mjg1ZDBlNWQ1MzBmYWVmMDAvdGFibGVyYW5nZTo3MDQxMTdmNjRmMzY0MTUyODVkMGU1ZDUzMGZhZWYwMF8wLTAtMS0xLTEwNzUzNw_38177d4b-9d19-4b39-b535-04575649dc01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzA0MTE3ZjY0ZjM2NDE1Mjg1ZDBlNWQ1MzBmYWVmMDAvdGFibGVyYW5nZTo3MDQxMTdmNjRmMzY0MTUyODVkMGU1ZDUzMGZhZWYwMF8wLTEtMS0xLTEwNzUzNw_c0482bb7-ecdc-4fc5-99ea-f72d6c847081">001-40215</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzA0MTE3ZjY0ZjM2NDE1Mjg1ZDBlNWQ1MzBmYWVmMDAvdGFibGVyYW5nZTo3MDQxMTdmNjRmMzY0MTUyODVkMGU1ZDUzMGZhZWYwMF8wLTItMS0xLTEwNzUzNw_acb04e75-64b0-40f4-881a-ea47d4884479">83-2072195</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOmZiYzQxZTlmNDgxOTRkNDY5ZDYwZmQ4NGJmMDI3MjRlXzU_1251bce5-2051-4890-8829-2cb83497dbf7">3963 Maple Avenue, Suite 350</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOmZiYzQxZTlmNDgxOTRkNDY5ZDYwZmQ4NGJmMDI3MjRlXzg_7da8730f-c745-479b-8c2d-513e491272fe">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOmZiYzQxZTlmNDgxOTRkNDY5ZDYwZmQ4NGJmMDI3MjRlXzEy_a1b57268-7e89-4f96-8850-d04d352e0dc0">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NjM4ZWFhNzdhNzAzNDRlMDljMzkxNjhiZjhlNmYzZWQvdGFibGVyYW5nZTo2MzhlYWE3N2E3MDM0NGUwOWMzOTE2OGJmOGU2ZjNlZF8xLTItMS0xLTEwNzUzNw_96419166-17f0-4e7c-bdaf-f1e1701efba6">75219</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ1_b6feede1-1cac-4e24-b3a9-eb86f9c4bd93">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ2_fc785d5d-bb09-4e1a-b2d7-b9cfc3079665">499-3350</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6MjhjZmViZWFhMTc3NGI2MGE5YTRmODJiNGM1YTgzYzQvdGFibGVyYW5nZToyOGNmZWJlYWExNzc0YjYwYTlhNGY4MmI0YzVhODNjNF8wLTAtMS0xLTEwNzUzNw_4e533fec-f412-4966-a81f-37f1259988ec">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6YzM0ZDRmNjA4ZDg3NDZlN2FhYTk1YzkyYWEzMWNlODQvdGFibGVyYW5nZTpjMzRkNGY2MDhkODc0NmU3YWFhOTVjOTJhYTMxY2U4NF8wLTAtMS0xLTEwNzUzNw_01b92cd9-62ec-4886-956e-39698d981d03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6ZjBhNjNmMWY0YzFhNDdkZjg0YTg5NjRiNmI0MDRkYWEvdGFibGVyYW5nZTpmMGE2M2YxZjRjMWE0N2RmODRhODk2NGI2YjQwNGRhYV8wLTAtMS0xLTEwNzUzNw_bf78f2b5-97fd-4a65-b499-998bc0bb3e8d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NzRiNTkzYWMyMmMxNDMxMWEzMGI2OTNhZjM4ZGMwNjkvdGFibGVyYW5nZTo3NGI1OTNhYzIyYzE0MzExYTMwYjY5M2FmMzhkYzA2OV8wLTAtMS0xLTEwNzUzNw_0b41d9f7-5fae-45ba-8bff-0d3195fde70a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NTEyODM5YWZkYjM2NDQ1ZGEwYjc2NDU2OThkMGUxMmEvdGFibGVyYW5nZTo1MTI4MzlhZmRiMzY0NDVkYTBiNzY0NTY5OGQwZTEyYV8xLTAtMS0xLTEwNzUzNw_97011d8f-633c-41ce-9f02-6486e22a4653">Common Stock, $0.000001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NTEyODM5YWZkYjM2NDQ1ZGEwYjc2NDU2OThkMGUxMmEvdGFibGVyYW5nZTo1MTI4MzlhZmRiMzY0NDVkYTBiNzY0NTY5OGQwZTEyYV8xLTItMS0xLTEwNzUzNw_5ae8c2d1-e8d8-446e-b099-d625c5560ca1">TIL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6NTEyODM5YWZkYjM2NDQ1ZGEwYjc2NDU2OThkMGUxMmEvdGFibGVyYW5nZTo1MTI4MzlhZmRiMzY0NDVkYTBiNzY0NTY5OGQwZTEyYV8xLTQtMS0xLTEwNzUzNw_c02f9954-1380-4cd8-bd7c-285e5ac8cd91">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ4_e8b68481-a70a-44f9-999a-1ce8c96e4f62">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV8yMzQ5_e8c814eb-ba94-4271-bd63-72dbc38f3368">false</dei:EntityExTransitionPeriod>
    <dei:DocumentPeriodEndDate
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGV4dHJlZ2lvbjphZGRiMjRlZmJhOTQ0MDZiOGM0OWUzN2I0YWMwZjQxYV81NDk3NTU4MTYyNDQ_15d52cd3-2c2a-4302-ae2c-b848f7cc9472">2023-05-11</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="if06a677972274e868f9b232838c40b92_D20230511-20230511"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhNzA2MDE0MThhNjQxNzhhMWY5NjRjMmVmZTczNTdjL3NlYzpiYTcwNjAxNDE4YTY0MTc4YTFmOTY0YzJlZmU3MzU3Y18xL2ZyYWc6YWRkYjI0ZWZiYTk0NDA2YjhjNDllMzdiNGFjMGY0MWEvdGFibGU6OWIzNjQ3MDI4ODI3NDAzZTkwMjE0ZGMxMGMwODI3NDkvdGFibGVyYW5nZTo5YjM2NDcwMjg4Mjc0MDNlOTAyMTRkYzEwYzA4Mjc0OV8zLTAtMS0xLTEwNzUzNy90ZXh0cmVnaW9uOjk4YThiMGI5MDdhMDQ4ZmVhOWM3YWEzN2FjOGE1MTFiXzU0OTc1NTgxMzkwMg_15d52cd3-2c2a-4302-ae2c-b848f7cc9472">2023-05-11</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +<XJU8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "W.*M6X[HH+.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NFG9#E&7"]-.("$Q"<0M2KPMHFFBQ*C=V].&K1."!^ 8^\_G
MSY);'83V$9^C#QC)8KH;7=<GH<.&G8B" $CZA$ZE<DKT4_/@HU,T/>,1@M(?
MZHA05]4:')(RBA3,P"(L1"9;HX6.J,C'"][H!1\^8Y=A1@-VZ+"G!+SDP.0\
M,9S'KH4;8(811I>^"V@68J[^B<T=8)?DF.R2&H:A')J<FW;@\/;T^)+7+6R?
M2/4:IU_)"CH'W+#KY-?F8;O?,5E7=5-4JX+S/>>B6HG[]?OL^L/O)NR\L0?[
MCXVO@K*%7W<AOP!02P,$%     @ MSBK5IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&N"XL%F9&05W.<29X5ANF.J[!J3L!3<\ACT<PH(+8:]T3WS_A@1>T/A_M L
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M!5[O&KQ1%,$PUS>G$_("SY'/HC*+N&*CUVZ05YI"_X\V3&0,ZB/C4!^-EH<
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" "W.*M6EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " "W.*M6!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +<XJU;C
MNB@L[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( +<XJU:97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ MSBK5J!:ZVI0!
M#!$  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( +<XJU:?H!OPL0(  .(,   -              "  90,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ MSBK5I>*NQS     $P(   L
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64$L%!@     )  D /@(  .@3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="til-20230511.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://instilbio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="til-20230511.htm">til-20230511.htm</File>
    <File>q1-23er.htm</File>
    <File>til-20230511.xsd</File>
    <File>til-20230511_lab.xml</File>
    <File>til-20230511_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "til-20230511.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "til-20230511.htm"
     ]
    },
    "labelLink": {
     "local": [
      "til-20230511_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "til-20230511_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "til-20230511.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "til",
   "nsuri": "http://instilbio.com/20230511",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "til-20230511.htm",
      "contextRef": "if06a677972274e868f9b232838c40b92_D20230511-20230511",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://instilbio.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "til-20230511.htm",
      "contextRef": "if06a677972274e868f9b232838c40b92_D20230511-20230511",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://instilbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001789769-23-000067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001789769-23-000067-xbrl.zip
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M&X]E+&^8^F 2%]7R3@T7O\#] .,!?L64$V*M$)DC<#6<V<\;W*?U.E#0G78
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MS);/G-^=5ZP3BGFNO^@TJQW!JB<9=ZD.%;+VI-M%&D0DQGG'\]1V#I8D[73
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MLV#"F)M]G6G<7<YW60!A_Y(ZW E;&7%')$EGD?G;D,)M2.'3+8X7GY^K!?[
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M4ANY$A:0!-8J(AIVD:BZ,+ZZKFG49D"@JY+T^7D#V39+CF?"!CS<EC9N<.M
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MORA97>SZ=K_DA1Z-ODI2)@+$.?@ZI4]BQ")?(L;C2"4R83%F?<7>LCPU@6_
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M5NP^B8_ZZLV+[2?9^L3\-R_^!U!+ P04    " "W.*M6.7 /*MP&  #L,@
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MT!EH\H.F/WA6!=?VFO^M7[-G1W3OR/TPTATB+".<[5\W<7ZT-YO=RE%7!7R
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MRF\KCKN)<)$\SMLBQAYW/^LT\9I)XK&>PL0^:1[B#E!XQOP@+M34N=B%MI.
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MRQ<  #/A   +              "  0    !Q,2TR,V5R+FAT;5!+ 0(4 Q0
M   ( +<XJU9L;Q,_)Q<  .JQ   0              "  ?07  !T:6PM,C R
M,S U,3$N:'1M4$L! A0#%     @ MSBK5M<1+)5I @  8@<  !
M     ( !22\  '1I;"TR,#(S,#4Q,2YX<V102P$"% ,4    " "W.*M68'_M
M7J8*  #_8   %               @ '@,0  =&EL+3(P,C,P-3$Q7VQA8BYX
M;6Q02P$"% ,4    " "W.*M6.7 /*MP&  #L,@  %               @ &X
M/   =&EL+3(P,C,P-3$Q7W!R92YX;6Q02P4&      4 !0 Y 0  QD,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
